Novartis says operating profit to grow again ahead of Sandoz spin off
The Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion.
Source link
The Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/YAXLLRYLLJIW3IL72L5LTH6N5M.jpg "Cementing ties, UAE buys 80 French-made Rafale warplanes"){kind=small}
